ArticlePharmaceutics2025

Development and Validation of LC-MS/MS Method for Nintedanib and BIBF 1202 Monitoring in Plasma of Patients with Progressive Pulmonary Fibrosis Associated with Systemic Sclerosis.

Anna Kiełczyńska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.